
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
2dx - CD47 2D crystallizationInfoProtein from Ravi Human membrane proteins for 2D crystallization trial, CD47. It is stable during expression and purification from SF9 cells. It is also stable in all detergents tested in detergent stability assay. The N-terminal domain (soluble) of CD47 has been crystallized (3D) in 0.2 M MgCl2, 0.1 M Bis-Tris pH 5.5, 25% PEG3350 at 21 C. We will set up initial 2D crystallization based on this condition using different lipids.Properties
X241 - Lipids in 3dx bufferDialysed against 100 mM Tris pH 5.5, 200mM NaCl, and, after 1 week, 2 mM MBCD. Matrix details: X241-CD47.xlsx.X241, results
| ||||||||
2dx - CD47 2D crystallizationInfoProtein from Ravi Human membrane proteins for 2D crystallization trial, CD47. It is stable during expression and purification from SF9 cells. It is also stable in all detergents tested in detergent stability assay. The N-terminal domain (soluble) of CD47 has been crystallized (3D) in 0.2 M MgCl2, 0.1 M Bis-Tris pH 5.5, 25% PEG3350 at 21 C. We will set up initial 2D crystallization based on this condition using different lipids.Properties
X241 - Lipids in 3dx bufferDialysed against 100 mM Tris pH 5.5, 200mM NaCl, and, after 1 week, 2 mM MBCD. Matrix details: X241-CD47.xlsx. | ||||||||
| Added: | ||||||||
| > > | X241, results | |||||||
| ||||||||
2dx - CD47 2D crystallizationInfoProtein from Ravi Human membrane proteins for 2D crystallization trial, CD47. It is stable during expression and purification from SF9 cells. It is also stable in all detergents tested in detergent stability assay. The N-terminal domain (soluble) of CD47 has been crystallized (3D) in 0.2 M MgCl2, 0.1 M Bis-Tris pH 5.5, 25% PEG3350 at 21 C. We will set up initial 2D crystallization based on this condition using different lipids.Properties
| ||||||||
| Changed: | ||||||||
| < < |
| |||||||
| > > |
| |||||||
X241 - Lipids in 3dx buffer | ||||||||
| Added: | ||||||||
| > > | Dialysed against 100 mM Tris pH 5.5, 200mM NaCl, and, after 1 week, 2 mM MBCD. | |||||||
Matrix details: X241-CD47.xlsx.
| ||||||||
2dx - CD47 2D crystallizationInfoProtein from Ravi | ||||||||
| Changed: | ||||||||
| < < | Human membrane proteins for 2D crystallization trial, CD47. It is stable during expression and purification from SF9 cells. It is all stable in the all detergent tested in detergent stability assays. The N-terminal domain (soluble) of CD47 have been crystallized (3D) in 0.2 M MgCl2, 0.1 M Bis-Tris pH 5.5, 25% PEG3350 at 21 C. We will set up some crystallization base on this condition using different lipids. | |||||||
| > > | Human membrane proteins for 2D crystallization trial, CD47. It is stable during expression and purification from SF9 cells. It is also stable in all detergents tested in detergent stability assay. The N-terminal domain (soluble) of CD47 has been crystallized (3D) in 0.2 M MgCl2, 0.1 M Bis-Tris pH 5.5, 25% PEG3350 at 21 C. We will set up initial 2D crystallization based on this condition using different lipids. | |||||||
Properties
X241 - Lipids in 3dx bufferMatrix details: X241-CD47.xlsx.
| ||||||||
2dx - CD47 2D crystallizationInfoProtein from Ravi Human membrane proteins for 2D crystallization trial, CD47. It is stable during expression and purification from SF9 cells. It is all stable in the all detergent tested in detergent stability assays. The N-terminal domain (soluble) of CD47 have been crystallized (3D) in 0.2 M MgCl2, 0.1 M Bis-Tris pH 5.5, 25% PEG3350 at 21 C. We will set up some crystallization base on this condition using different lipids. | ||||||||
| Added: | ||||||||
| > > |
Properties
| |||||||
X241 - Lipids in 3dx bufferMatrix details: X241-CD47.xlsx.
| ||||||||
2dx - CD47 2D crystallizationInfoProtein from Ravi Human membrane proteins for 2D crystallization trial, CD47. It is stable during expression and purification from SF9 cells. It is all stable in the all detergent tested in detergent stability assays. The N-terminal domain (soluble) of CD47 have been crystallized (3D) in 0.2 M MgCl2, 0.1 M Bis-Tris pH 5.5, 25% PEG3350 at 21 C. We will set up some crystallization base on this condition using different lipids.X241 - Lipids in 3dx bufferMatrix details: X241-CD47.xlsx.
|